Allianz Asset Management GmbH Has $63.86 Million Stock Holdings in Encompass Health Corporation $EHC

Allianz Asset Management GmbH boosted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 9.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 502,746 shares of the company’s stock after buying an additional 42,741 shares during the period. Allianz Asset Management GmbH owned approximately 0.50% of Encompass Health worth $63,859,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Bridges Investment Management Inc. bought a new position in Encompass Health during the 3rd quarter worth about $270,000. Jones Financial Companies Lllp increased its stake in Encompass Health by 42.9% in the 3rd quarter. Jones Financial Companies Lllp now owns 982 shares of the company’s stock valued at $124,000 after buying an additional 295 shares during the last quarter. State of Wyoming grew its holdings in shares of Encompass Health by 38.8% in the 3rd quarter. State of Wyoming now owns 3,906 shares of the company’s stock valued at $496,000 after acquiring an additional 1,092 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Encompass Health by 19.0% in the third quarter. Principal Financial Group Inc. now owns 271,876 shares of the company’s stock valued at $34,534,000 after acquiring an additional 43,379 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in Encompass Health by 57.8% during the third quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock worth $151,544,000 after acquiring an additional 437,464 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC stock opened at $95.64 on Thursday. The company has a market capitalization of $9.62 billion, a P/E ratio of 18.08, a PEG ratio of 1.52 and a beta of 0.73. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The company has a fifty day moving average price of $104.81 and a 200-day moving average price of $114.55. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14.

Wall Street Analyst Weigh In

EHC has been the subject of several recent analyst reports. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Barclays increased their price objective on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Finally, Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.